Ikarian Capital’s Nuvalent NUVL Stock Holding History

Ikarian Capital’s Portfolio NUVL Stock Details NUVL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.42M	Sell	23,594 -36,000	-60%	-$3.67M	0.2%	92
2025 Q4	$5.99M	Buy	+59,594	New	+$5.88M	0.47%	58
2025 Q1	–	Sell	-52,216	Closed	-$4.09M	–	201
2024 Q4	$4.09M	Sell	52,216 -22	-0%	-$2.06K	0.56%	53
2024 Q3	$5.34M	Sell	52,238 -99,363	-66%	-$8.24M	0.75%	34
2024 Q2	$11.5M	Buy	151,601 +50,000	+49%	+$3.56M	2%	17
2024 Q1	$7.63M	Sell	101,601 -156,541	-61%	-$12.5M	0.84%	41
2023 Q4	$19M	Sell	258,142 -19,892	-7%	-$1.23M	1.78%	17
2023 Q3	$12.8M	Buy	278,034 +5,282	+2%	+$234K	1.54%	16
2023 Q2	$11.5M	Buy	+272,752	New	+$10.3M	1.83%	15

Other funds holding NUVL

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Ikarian Capital's NUVL Position: Q1 2026 in Review

Ikarian Capital reduced its Nuvalent (NUVL) stake by 60% in Q1 2026, selling an estimated $3.67M and leaving 23,594 shares worth $2.42M. The position accounts for 0.2% of the portfolio, ranked #92.

Ikarian Capital first reported a position in NUVL in Q2 2023 and has held it in 9 quarters since. The position peaked at $19M in Q4 2023. 263 funds tracked by Wall St. Rank hold NUVL as of Q1 2026.

Ikarian Capital held 23,594 shares of Nuvalent worth $2.42M as of Q1 2026.
Ikarian Capital sold 36,000 Nuvalent shares in Q1 2026, an estimated $3.67M.
Nuvalent made up 0.2% of Ikarian Capital's portfolio in Q1 2026, its #92 holding.
Ikarian Capital first reported a position in Nuvalent in Q2 2023 and has held it in 9 quarters since.
Ikarian Capital's Nuvalent position peaked at $19M in Q4 2023.
263 funds tracked by Wall St. Rank held Nuvalent as of Q1 2026.

Based on Ikarian Capital's 13F filing for Q1 2026, filed 15 May 2026.